title: Whole-body MRI and FDG PET fused images for evaluation of patients with cancer.
abstract: OBJECTIVE
  The purpose of this article is to illustrate the feasibility of fused whole-body MRI and PET for the evaluation of patients with cancer.
  
  
  CONCLUSIONS
  MRI has proven to be superior to CT for studying several regions of the body, and PET FDG has become an established diagnostic tool in oncology. Because FDG accumulates avidly in tumor tissue, fusing FDG PET to whole-body MRI allows good anatomy-based evaluation of disease.
authors.affiliation: Clinics Multi-Imagem and Clínica de Diagnóstico Por Imagem and Department of Radiology of the Federal University of Rio de Janeiro, Av. Das Américas 4666 sl 325, Rio de Janeiro, RJ, Brazil. rcdomingues@yahoo.com
authors.forename: Roberto C
authors.initials: RC
authors.lastname: Domingues
authors.forename: Michel P
authors.initials: MP
authors.lastname: Carneiro
authors.forename: Fernanda Cristina Rueda
authors.initials: FC
authors.lastname: Lopes
authors.forename: Romeu C
authors.initials: RC
authors.lastname: Domingues
authors.forename: Lea Mirian Barbosa
authors.initials: LM
authors.lastname: da Fonseca
authors.forename: Emerson L
authors.initials: EL
authors.lastname: Gasparetto
mesh_terms: D003287:Contrast Media; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009369:Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed / Q000379:methods; D051598:Whole Body Imaging
chemical_list: D003287:Contrast Media; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18